Tim Ring


Mr. Ring co-founded TEAMFund to foster the development of world-class medical technologies suited to the needs of low-to-middle income populations. He currently serves as a Director on the Boards of Becton Dickinson (NYSE: BDX) and Quest Diagnostics (NYSE: DGX). Before TEAMFund, he served as Chairman and CEO of C.R. Bard from 2003 through its sale to Becton Dickinson for $24 billion in 2017.

Prior Experience

  • Board Director, CIT Holdings
  • Board Chairman, Healthcare Institute of New Jersey
  • Foundation Trustee, University of Medicine and Dentistry of New Jersey
  • General Manager Australia, Indonesia (and other roles), Abbott Laboratories


  • B.S., Cornell University